针对肠病毒EV71的抗病毒药物(合成小分子抑制剂和天然药物):进展和展望

Yuwei Liu , Yuan Xi , Likai Ji , Quan Shen , Wen Zhang , Mengzhu Xue
{"title":"针对肠病毒EV71的抗病毒药物(合成小分子抑制剂和天然药物):进展和展望","authors":"Yuwei Liu ,&nbsp;Yuan Xi ,&nbsp;Likai Ji ,&nbsp;Quan Shen ,&nbsp;Wen Zhang ,&nbsp;Mengzhu Xue","doi":"10.1016/j.ccmp.2023.100099","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Enterovirus 71 (EV71) is a major virus that causes hand-foot-mouth disease. In cases of infants and young children, EV71 infection has been associated with severe neurological disease and potentially fatal systemic complications. The sporadic outbreak worldwide is increasingly prevalent in the Asia-Pacific region, where it has become a major public health concern.</p></div><div><h3>Objective</h3><p>No specific antiviral drugs are currently approved for the treatment of EV71 infection. The purpose of this study is to comprehensively review the research progress of anti-EV71 drugs (synthetic small molecule inhibitors and nature drugs) in the past twenty years, and further to promote the research and development of antiviral drugs against enterovirus infection.</p></div><div><h3>Methods</h3><p>This study reviewed the drugs on anti EV71 in the past decades. The literature search in PubMed database was conducted for original studies and review articles on drugs against enterovirus 71. Related articles published in English were selected for study and discussion.</p></div><div><h3>Results</h3><p>As reviewed in this paper, bioactive molecules include receptor analogues, protease inhibitors, natural drugs derived from traditional chinese medicine or natural medicine. These bioactive molecules have shown significant effectiveness in inhibiting the entry and replication of EV71 <em>in vitro</em> and <em>in vivo</em> experiments.</p></div><div><h3>Conclusion</h3><p>This review demonstrated that the entry receptor of EV71 into host cells has been studied, and receptor drugs against enterovirus have been made some progress, but most receptor analogues have not been reported. Further research is needed in this area in the future. On the other hand, the protease inhibitors have always been a major aspect of anti-enterovirus research and can be developed as antiviral agents for clinical application. In terms of natural drugs, many monomers derived from traditional chinese medicine or natural medicine have good antiviral activity and little toxic and side effects on host cells, but in view of their multi-target properties, the mechanism of drug action needs to be further studied.</p></div>","PeriodicalId":72608,"journal":{"name":"Clinical complementary medicine and pharmacology","volume":"3 4","pages":"Article 100099"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antiviral Drugs (Synthetic Small Molecule Inhibitors and Nature Drugs) Against EV71 in Enteroviruses: Advances and Perspectives\",\"authors\":\"Yuwei Liu ,&nbsp;Yuan Xi ,&nbsp;Likai Ji ,&nbsp;Quan Shen ,&nbsp;Wen Zhang ,&nbsp;Mengzhu Xue\",\"doi\":\"10.1016/j.ccmp.2023.100099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Enterovirus 71 (EV71) is a major virus that causes hand-foot-mouth disease. In cases of infants and young children, EV71 infection has been associated with severe neurological disease and potentially fatal systemic complications. The sporadic outbreak worldwide is increasingly prevalent in the Asia-Pacific region, where it has become a major public health concern.</p></div><div><h3>Objective</h3><p>No specific antiviral drugs are currently approved for the treatment of EV71 infection. The purpose of this study is to comprehensively review the research progress of anti-EV71 drugs (synthetic small molecule inhibitors and nature drugs) in the past twenty years, and further to promote the research and development of antiviral drugs against enterovirus infection.</p></div><div><h3>Methods</h3><p>This study reviewed the drugs on anti EV71 in the past decades. The literature search in PubMed database was conducted for original studies and review articles on drugs against enterovirus 71. Related articles published in English were selected for study and discussion.</p></div><div><h3>Results</h3><p>As reviewed in this paper, bioactive molecules include receptor analogues, protease inhibitors, natural drugs derived from traditional chinese medicine or natural medicine. These bioactive molecules have shown significant effectiveness in inhibiting the entry and replication of EV71 <em>in vitro</em> and <em>in vivo</em> experiments.</p></div><div><h3>Conclusion</h3><p>This review demonstrated that the entry receptor of EV71 into host cells has been studied, and receptor drugs against enterovirus have been made some progress, but most receptor analogues have not been reported. Further research is needed in this area in the future. On the other hand, the protease inhibitors have always been a major aspect of anti-enterovirus research and can be developed as antiviral agents for clinical application. In terms of natural drugs, many monomers derived from traditional chinese medicine or natural medicine have good antiviral activity and little toxic and side effects on host cells, but in view of their multi-target properties, the mechanism of drug action needs to be further studied.</p></div>\",\"PeriodicalId\":72608,\"journal\":{\"name\":\"Clinical complementary medicine and pharmacology\",\"volume\":\"3 4\",\"pages\":\"Article 100099\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical complementary medicine and pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772371223000219\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical complementary medicine and pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772371223000219","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景肠病毒71 (EV71)是引起手足口病的主要病毒。在婴幼儿病例中,EV71感染与严重的神经系统疾病和可能致命的全身并发症有关。世界范围内的散发疫情在亚太地区日益流行,已成为一个主要的公共卫生问题。目的目前还没有特异性抗病毒药物被批准用于治疗EV71感染。本文旨在全面综述近二十年来抗ev71病毒药物(合成小分子抑制剂和天然药物)的研究进展,进一步促进抗肠病毒感染药物的研究与开发。方法对近几十年来国内外抗EV71型病毒的药物进行综述。在PubMed数据库中检索有关肠病毒71型药物的原始研究和综述文章。选取相关的英文文章进行研究和讨论。结果生物活性分子包括受体类似物、蛋白酶抑制剂、源自中药或天然药物的天然药物等。这些生物活性分子在体外和体内实验中显示出显著的抑制EV71病毒进入和复制的有效性。结论对EV71进入宿主细胞的受体进行了研究,抗肠病毒的受体药物也取得了一定进展,但大多数受体类似物尚未见报道。这方面的研究还有待进一步深入。另一方面,蛋白酶抑制剂一直是抗肠病毒研究的一个重要方面,可以作为抗病毒药物开发用于临床应用。在天然药物方面,许多来自中药或天然药物的单体具有良好的抗病毒活性,对宿主细胞的毒副作用小,但鉴于其多靶点特性,其药物作用机制有待进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Antiviral Drugs (Synthetic Small Molecule Inhibitors and Nature Drugs) Against EV71 in Enteroviruses: Advances and Perspectives

Antiviral Drugs (Synthetic Small Molecule Inhibitors and Nature Drugs) Against EV71 in Enteroviruses: Advances and Perspectives

Background

Enterovirus 71 (EV71) is a major virus that causes hand-foot-mouth disease. In cases of infants and young children, EV71 infection has been associated with severe neurological disease and potentially fatal systemic complications. The sporadic outbreak worldwide is increasingly prevalent in the Asia-Pacific region, where it has become a major public health concern.

Objective

No specific antiviral drugs are currently approved for the treatment of EV71 infection. The purpose of this study is to comprehensively review the research progress of anti-EV71 drugs (synthetic small molecule inhibitors and nature drugs) in the past twenty years, and further to promote the research and development of antiviral drugs against enterovirus infection.

Methods

This study reviewed the drugs on anti EV71 in the past decades. The literature search in PubMed database was conducted for original studies and review articles on drugs against enterovirus 71. Related articles published in English were selected for study and discussion.

Results

As reviewed in this paper, bioactive molecules include receptor analogues, protease inhibitors, natural drugs derived from traditional chinese medicine or natural medicine. These bioactive molecules have shown significant effectiveness in inhibiting the entry and replication of EV71 in vitro and in vivo experiments.

Conclusion

This review demonstrated that the entry receptor of EV71 into host cells has been studied, and receptor drugs against enterovirus have been made some progress, but most receptor analogues have not been reported. Further research is needed in this area in the future. On the other hand, the protease inhibitors have always been a major aspect of anti-enterovirus research and can be developed as antiviral agents for clinical application. In terms of natural drugs, many monomers derived from traditional chinese medicine or natural medicine have good antiviral activity and little toxic and side effects on host cells, but in view of their multi-target properties, the mechanism of drug action needs to be further studied.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical complementary medicine and pharmacology
Clinical complementary medicine and pharmacology Complementary and Alternative Medicine
自引率
0.00%
发文量
0
审稿时长
67 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信